82 related articles for article (PubMed ID: 2167410)
21. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
22. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.
Hara J; Kawa-Ha K; Yumura-Yagi K; Kurahashi H; Tawa A; Ishihara S; Inoue M; Murayama N; Okada S
Leukemia; 1991 Jan; 5(1):19-25. PubMed ID: 1705635
[TBL] [Abstract][Full Text] [Related]
24. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
Bártová E; Harnicarová A; Pacherník J; Kozubek S
Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
[TBL] [Abstract][Full Text] [Related]
25. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
26. Lineage non-specific down regulation of P210bcr/abl in the CML cell line, KU-812-F, during differentiation.
Takahira H; Nishimura J; Shibata K; Hirata J; Umemura T; Nawata H
Leuk Res; 1990; 14(9):801-8. PubMed ID: 2232852
[TBL] [Abstract][Full Text] [Related]
27. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
29. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
[TBL] [Abstract][Full Text] [Related]
30. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of a new human erythroleukemic cell line, ERY-1.
Ribadeau Dumas A; Hamouda NB; Leriche L; Piffaut MC; Bonnemye P; Kuen RL; Tricottet V; Merle-Beral H; N'Guyen Khac F; Arock M
Leuk Res; 2004 Dec; 28(12):1329-39. PubMed ID: 15475075
[TBL] [Abstract][Full Text] [Related]
32. [Biphenotypic acute leukemia with Ph1 chromosome, M-BCR-, myeloperoxidase+, and CALLA+].
Nagata K; Hatanaka T; Yamamoto K; Ito T; Saito M; Ono Y; Kamiya O; Ohara K; Hoshino A; Yamazaki K
Rinsho Ketsueki; 1991 Mar; 32(3):231-8. PubMed ID: 1645807
[TBL] [Abstract][Full Text] [Related]
33. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
[TBL] [Abstract][Full Text] [Related]
34. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins.
Casnici C; Volpe G; Crotta K; Panuzzo C; Lattuada D; Cabras CA; Longhi R; Saglio G; Marelli O
Hybridoma (Larchmt); 2011 Jun; 30(3):261-9. PubMed ID: 21707361
[TBL] [Abstract][Full Text] [Related]
36. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells.
Okuno Y; Suzuki A; Ichiba S; Takahashi T; Nakamura K; Hitomi K; Sasaki R; Tada K; Imura H
Cancer; 1990 Oct; 66(7):1544-51. PubMed ID: 2169992
[TBL] [Abstract][Full Text] [Related]
37. Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells.
Schuh AC; Sutherland DR; Horsfall W; Mills GB; Dube I; Baker MA; Siminovitch K; Bailey D; Keating A
Leukemia; 1990 Sep; 4(9):631-6. PubMed ID: 2168506
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.
Ohyashiki K; Miyauchi J; Ohyashiki JH; Saito M; Yaguchi M; Inatomi Y; Nakazawa S; Waca H; Mizutani S; Matsuo Y
Leukemia; 1993 Jul; 7(7):1034-40. PubMed ID: 7686604
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]